Organization Profile

You just read:

OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427

News provided by

OncoGenex Pharmaceuticals, Inc.

Aug 02, 2012, 16:02 ET